Inhaled nitric oxide and intravenous magnesium sulphate for the treatment of persistent pulmonary hypertension of the newborn

Singapore Medical Journal

Volumn 51, Issue 2, 2010, Pages 144-150

  Boo, N Y ^a   Rohana, J ^a   Yong, S C ^a   Bilkis, A Z ^a   Yong Junina, F ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Inhaled nitric oxide; Intravenous magnesium sulphate; PPHN

Indexed keywords

MAGNESIUM SULFATE; NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HIGH FREQUENCY VENTILATION; HUMAN; INTENSIVE CARE UNIT; MAGNESIUM BLOOD LEVEL; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; PERSISTENT PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; FEMALE; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INTENTION TO TREAT ANALYSIS; MAGNESIUM SULFATE; MALE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY THERAPY; SURVIVAL ANALYSIS; VASODILATOR AGENTS;

EID: 77951275446     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Clark RH. High-frequency ventilation. J Pediatr 1994; 124:661-70.
2. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-20.
3. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997; 131:55-62.
4. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006; 4:CD000399.
5. Abu-Osba YK, Galal O, Manasra K, Rejjal A. Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992; 67:31-5.
6. Tolsa JF, Cotting J, Sekarski N, Payot M, Micheli JL, Calame A. Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child 1995; 72:F184-F187.
7. Daffa SH, Milaat WA. Role of magnesium sulphate in treatment of severe persistent pulmonary hypertension of the newborn. Saudi Med J 2002; 23:1266-9.
8. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulphate given for neuroprotection before preterm birth: a randomised controlled trial. JAMA 2003; 290:2669-76.
9. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weghts less than 1,500 gm. J Pediatr 1978; 92:529-34.
10. Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J.Med 2000; 342:469-74.
11. Altura BM, Altura BT, Carella A, Turlapaty PD. Hypomagnesemia and vasoconstriction: possible relationship to etiology of sudden death ischemic heart disease and hypertensive vascular diseases. Artery 1981; 9:212-31.
12. 2+ currents of capillary endothelial cells from rat brain. FEBS Lett 1996; 394:335-9.
13. Dichtl A, Vierling W. Inhibition by magnesium of calcium inward current in heart ventricular muscle. Eur J Pharmacol 1991; 204:243-48.
14. Konduri GG. New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol 2004; 31:591-611.
15. Chirstou H, Van Marter LJ, Wessel DL, et al. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 2000; 28:3722-7.
16. Tworetzky W, Bristow J, Moore P, et al. Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Lancet 2001; 357:118-20.
17. Haas KM, Suzuki S, Yamaguchi N, et al. Nitric oxide further attenuates pulmonary hypertension in magnesium-treated piglets. Pediatr Int 2002; 44:670-4.